Trending
- How transition finance can catalyse Africa’s green industrial revolution
- Stanbic PMI Report: Mixed performance as Kenya’s agriculture, construction offset manufacturing decline
- Uganda’s land management gets a tech makeover to boost transparency
- Nigeria’s output dips fastest in 19 months on a sharp rise in costs
- Apple faces growing backlash over Congo exploitation
- Why East Africa is staring at higher wheat prices in 2025
- Nairobi Gate SEZ pumps $7 million into Kenya’s agro-processing industry
- What impact will the US election have on Africa?
Browsing: COVID-19 Vaccine africa
- Bill & Melinda Gates Foundation, the Swedish International Development Cooperation Agency (SIDA), and UNICEF said the financing will help sustain national immunization programs
- These will include COVID-19 vaccination campaigns, and enable the timely procurement of essential health supplies while domestic financing is mobilized
- Access to diagnostics, treatments, vaccines and other essential health supplies is critical to ensuring that countries can protect their people against COVID-19 and other health threats
Three organizations have announced a $150 million financial guarantee to help UNICEF procure vaccines and other health-related supplies for low- and middle-income countries (LMICs).
The three, Bill & Melinda Gates Foundation, the Swedish International Development Cooperation Agency (SIDA), and UNICEF said the financing will help sustain national immunization programs.
These will include COVID-19 vaccination campaigns, and enable the timely procurement of essential health supplies while domestic financing is mobilized.
The financing will be effective through 2025.
According to the partners, many …
COVID-19 Vaccine On African Soil
South African Aspen Pharmacare, a wholly-owned subsidiary of Aspen Holdings, has entered into an arrangement with Janssen Pharmaceutical, an arm of Johnson & Johnson, for the commercial reproduction of candidate COVID vaccine Ad26.COV2-S.
Aspen Pharmacare will do the formulation, filling as well as secondary packaging of the vaccine. After which it will be supplied to Johnson & Johnson.
COVID-19 Vaccine
The fine print of the agreement, including the terms of manufacturing, is yet to be concluded. Further, the technology transfer required to complete the successful implementation of the deal has not yet been finalized.
The manufacturing will be done at one of Aspen Pharmacare’s sterile facilities, which has the capacity to produce 300 million doses per annum, located in Port Elizabeth, South Africa.
Currency, the proposed vaccine is undergoing clinical trials.
To date, Aspen has poured in over $3 million of investment to prepare the …